Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

The RNA N6 -methyladenosine modulator HNRNPA2B1 is involved in the development of non-small cell lung cancer.

Clinical and experimental pharmacology & physiology - 1 Mar 2022

Jin Luming, Chen Chaoyang, Yao Jianyu, Yu Zhichen, Bu Liang

Abstract excerpt

The key N6 methyladenosine (m6 A) RNA methylation regulator is associated with multiple tumour progression. However, the m6 A-associated regulators that influence non-small cell lung cancer (NSCLC) development have not been fully clarified. The m6 A regulator expression pattern of NSCLC patients from The Cancer Genome Atlas (TCGA) dataset was identified. Aberrations of m6A modulators are related to NSCLC...

Topics

Join the communities discussing this publication.

Adenosine
Aged
Alpha-Ketoglutarate-Dependent Dioxygenase FTO
Carcinoma, Non-Small-Cell Lung
Databases, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Gene Expression Regulation, Neoplastic

RNA-Binding Proteins

Source

Identifiers

PMID: 34717005
DOI: 10.1111/1440-1681.13608

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The RNA N6 -methyladenosine modulator HNRNPA2B1 is involved in the development of non-small cell lung cancer.PMID 34717005Read ↗

M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancerSemantic proximity Read ↗

Construction of a m6A RNA Methylation Regulator-related Signature for Prognosis and Immune Response in Lung AdenocarcinomaSemantic proximity Read ↗

Deciphering N6‐Methyladenosine‐Related Genes Signature to Predict Survival in Lung AdenocarcinomaSemantic proximity Read ↗

Expression Status and Prognostic Value of m6A RNA Methylation Regulators in Lung AdenocarcinomaSemantic proximity Read ↗

Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell CarcinomaSemantic proximity Read ↗

Comprehensive analysis of the prognostic role and mutational characteristics of m6A-related genes in lung adenocacinomaSemantic proximity Read ↗

M6a Regulator-Mediated RNA Methylation modification Patterns Correlated With Prognosis Value and Immune Response in Adenocarcinoma of lungSemantic proximity Read ↗

m6A-Mediated Methylation Patterns and Their Association With Obstructive Sleep Apnea in Lung Adenocarcinoma.Semantic proximity Read ↗

Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer typesSemantic proximity Read ↗

Characterization of m6A RNA Methylation Regulators Predicts Survival and Immunotherapy in Lung Adenocarcinoma.Semantic proximity Read ↗

Expression and prognostic significance of m6A-related genes in TP53-mutant non-small-cell lung cancer.Semantic proximity Read ↗

Expression and Prognostic Significance of m6A-Related Genes in TP53-Mutant Non-Small-Cell Lung CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.